Clinical Trial Update: Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and effectiveness of the A-dmDT390-bisFv(UCHT1) fusion protein in patients with mycosis fungoides; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides

Drugs mentioned

• A-dmDT390-bisFv(UCHT1) fusion protein

Snippet

Sponsor: Angimmune LLC | Conditions: Mycosis Fungoides | Phase 2 | Status: UNKNOWN